Brochures

Webinars

View the Webinar

Transdermal Drug Delivery – Is it feasible for your drug?

This webinar shows the components of a TTS, and how it can be used to provide a genuine alternative to current drug delivery methods. In this sense, this presentation aims to ascertain whether TTS should be chosen as a first choice dosage form.

Presented by: Dr. Peter Klaffenbach, Head of Pharmceutical Development & Dr. Iris Schnitzler, Director Marketing and Market Services

View the Webinar

Oral Thin Films – New opportunities for oral drug delivery.

This webinar shows the components and science of OTFs; features and benefits; applications in various disease areas; and potential penetration of market and respective market share through its use and adoption.

Presented by: Rick Chan Phd, Vice President, R & D & Dr. Iris Schnitzler, Director Marketing and Market Services

View the Webinar

Current guidelines and practical experience – Analytic considerations for testing transdermal delivery systems.

The webinar focuses on the analysis of drug-in-adhesive (DIA) patches with systemic drug delivery by passive diffusion.
It considers both the main guideline documents as well as practical experience in TDS analytics gained at LTS over the past years.

Presented by: Dr. Michael Komenda, Corporate Senior Director, Head of Analytical Development R & D

View the Webinar

Transdermal Delivery Systems – What are the requirements for pressure sensitive adhesives?

This webinar shows the physico-chemical properties of pressure sensitive adhesives, and their importance for providing TDS with reversible adhesion to the skin.

Presented by: Dr. Thomas Hille, Director R&D

View the Webinar

Oral Thin Films – Tailoring Therapy Need

This webinar shows the components and science of OTFs and how they can be used to provide a genuine alternative to current drug delivery methods – and be considered as a genuine alternative dosage form. The webinar highlighs the market potential and increased market share of OTF products.

Presented by: Dr. Marco Emgenbroich, Corporate Vice President Head of Pharmaceutical Development

View the Webinar

Transdermal Therapeutic Systems – Still an attractive technology?!

This webinar shows the characteristics and advantages of TTS in relation to the feasibility of its usage to better/alternatively administer pharmaceutical actives and the novel possibilities to assess these advantages. The webinar will explore the history of the market success of TTS and the reasons therefore. The webinar will also give an outlook on what is coming next in transdermal drug delivery e.g. microneedle systems.

Presented by: Dr. Marco Emgenbroich, Corporate Vice President Head of Pharmaceutical Development